Good Morning! This exclusive edition of The Funding Letter comes to you from our headquarters in New York City. 🔥New Sales Gigs from Unlearn below!
Hit the Gong 🎉
Source: @overheard_sales
Looking for visuals and charts, rather than words, to understand the daily news?
Bay Area Times is a visual-based newsletter on business and tech, with 250,000+ subscribers.
Daily Deals 💸
🌎 Americas
BioAge Labs provides drug therapy to treat specific age-related diseases and to extend human health span and lifespan, enabling people to combat the suffering and disability caused by all aging-related diseases and restore both the quality and quantity of life in old age. View on: LinkedIn.com | Sales Navigator.
New Funding Raised: $170M, Series D
Round Investors: Sofinnova Investments (lead), OrbiMed, Lilly Ventures, Andreessen Horowitz
🚀Growth Focus: Advance Phase 2 clinical trials of azelaprag, an apelin receptor agonist, in combination with Lilly’s Zepboundand therapeutic pipeline.
HQ: Richmond, CA
Industry: Biotechnology Research
Employee Count: 80